BioSpace News Archive

A team of scientists at Gladstone Institutes and UC San Francisco (UCSF) is launching the Gladstone-UCSF Center for Neurovascular Brain Immunology to study neurological diseases in a unique way that could lead to the development of novel treatments.

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, today announced its intention to offer its American Depositary Shares (“ADSs”) in an underwritten public offering

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its pipeline of late-stage product candidates, and an activity report for the second quarter ended December 31, 2020.

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced a new collaboration agreement with MAbSilico, a deep technology innovative TechBio located in Tours, France, to use artificial intelligence (AI)-based software for therapeutic monoclonal antibody drug development.

AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update:

Micro Interventional Devices, Inc.™ (MID) announced today that it has submitted the required technical documentation for CE Mark approval for its MIA-T™ Percutaneous Tricuspid Annuloplasty System for tricuspid valve repair to its Notified Body.

The Versiti Blood Research Institute has been awarded a $12.3 million research grant by the National Institutes of Health’s National Heart, Lung and Blood Institute to support Versiti’s research of how blood production is governed by sugars and how sugars change amid cancer and disease.

Growing skin problems and a higher awareness regarding new treatments will fuel photorejuvenation devices market share over the forecast period.

Pharmacy Launched During Pandemic Through Joint Venture Funding Drives New Source of Revenue For Hospital And Expands Services To Patients

The surge in pollution levels globally resulting in a growing number of respiratory disorders would drive the pneumatic nebulizers market growth.